Business · Companies · 2 hrs ago
Hypera reports third-quarter profit of R$523 million, up 14.7%
Hypera announced its third-quarter 2026 results on October 27.
Net profit reached R$523 million, 14.7% higher than a year earlier.
Revenue rose more than 9% to R$2.44 billion.
The company is a pharmaceutical maker, and its results reflect sales of its products.
Its Semavy weight-loss pen helped lift profit during the quarter.
Sales of antigripal medicines fell, but Semavy helped offset that decline.
The results do not say what the company expects next.
Hypera reported net profit of R$527 million for the third quarter, up 16.1% from a year earlier.
Net revenue rose 9.4% to R$2.44 billion from July through September.
The results exceeded analysts’ average forecasts of R$471.4 million in profit and R$2.4 billion in revenue.
The company attributed growth to stronger pharmacy sales and the launch of its semaglutide product, Semavy.
Higher marketing and sales costs weighed on operating margin, while lower financial expenses supported profit.
- Who
- Brazilian pharmaceutical company Hypera.
- What
- It reported third-quarter net profit of R$527 million, up 16.1% year on year.
- When
- The results were announced on October 27, 2026, covering July through September.
- Where
- Brazil.
- Why
- The company cited stronger pharmacy sales and the launch of Semavy; lower financial expenses also supported profit.
This story does not have two clearly opposing sides.
Semavy arrived in pharmacies in Brazil, according to Exame.
About 93,000 Semavy units were sold to consumers, according to company-cited IQVIA data.
Hypera announced its third-quarter results.
- Net profit
- R$527 million; up 16.1% year on year
- Net revenue
- R$2.44 billion; up 9.4% year on year
- Ebitda
- R$782.3 million; up 3.4% year on year
- Semavy sales
- About 93,000 units in September
- Semavy distribution
- More than 18,000 points of sale in September
- Analysts’ average profit forecast
- R$471.4 million
5 sources
Caneta emagrecedora faz lucro da Hypera Pharma subir 16,1% no 3º trimestre
Hypera (HYPE3) tem lucro de R$527 mi no 3º tri
Hypera tem lucro de R$ 527 milhões no 3° tri, avanço de 16,1%
Hypera registra lucro líquido de R$ 523 mi no terceiro tri, alta de 14,7%
Caneta emagrecedora compensa queda dos antigripais no balanço da Hypera do 3º tri